Abdominal aortic aneurysm expansion rate: Effect of size and beta-adrenergic blockade
|
|
- Alisha Bridges
- 6 years ago
- Views:
Transcription
1 Abdominal aortic aneurysm expansion rate: Effect of size and beta-adrenergic blockade Gregory R. Gadowski, MD, David B. Pilcher, MD, and Michael A. Ricci, MD, Burlington, Vt. Purpose: The purpose of this study was to investigate the hypothesis that abdominal aortic aneurysm (AAA) expansion may be slowed by -adrenergic antagonists. Methods: One hundred twenty-one patients with infrarenal AAA were monitored with serial aortic ultrasound examinations. Eighty-three patients received no -blockers (group I), and 38 patients received -blockers (group II). Values are expressed as mean ± SD. Results: The me'\d follow-up was 43 ± 29 months with 5.5 ± 3.4 ultrasound examinations per patient. The expansion rate among all AAA was 0.38 ± 0.44 cm/yr. Large aneurysms (5 cm) expanded significantly faster than small aneurysms (p = 0.02) in patients not treated with -blockers. Among patients with large AAA, those receiving -blockers had a significantly reduced mean expansion rate; 0.36 ± 0.20 versus 0.68 ± 0.64 cm/yr, (p < 0.05). Although rupture rates were lower in group I (5%) versus group II (13%), this difference was not statistically significant. Thirty-four patients in a poor-risk category with AAA were monitored greater than 5 cm in diameter. Ten of these AAA ruptured. The mean expansion rate was significantly greater in those patients with ruptured AAA versus those patients with AAA that did not rupture; 0.82 ± 0.74 versus 0.42 ± 0.41 cm/yr (p = 0.04). Conclusions: In patients not undergoing -blocker therapy, large AAA expand at a significantly greater rate than smaller AAA. Large aneurysms that rupture show more rapid expansion than those AAA that do not rupture. We have demonstrated a significantly reduced rate of expansion of large AAA in patients receiving -blockade. (J VAse SURG 1994;19: ) Large abdominal aortic aneurysms (AAA), more than 5 cm in diameter, have an approximate risk of rupture of 30% within 5 years. Although elective surgical resection is the preferred treatment, care of patients with smaller aneurysms or those with medical contraindications to surgery is less well defined. In those situations, nonoperative measures that would retard AAA enlargement or prevent rupture would be beneficial. The suggestion that pharmacologic therapy might slow AAA expansion was first made by Leach and coworkers2 in In their retrospective study, From the Department of Surgery, University of Vermont College of Medicine, Burlington. Presented at the Third Annual Winter Meeting of the Peripheral Vascular Surgery Society, Brekenridge, Colo. January 25,1993. Reprint requests: David B. Pilcher, MD, Department of Surgery, University Health Center, 1 S. Prospect St., Burlington, VT 0540l. Copyright 1994 by The Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter /94/$ /1/51145 they found that -adrenergic blockade significantly reduced rapid AAA expansion and, in general, tended to slow aneurysm growth. This clinical observation is especially intriguing in light of growing experimental evidence suggesting that -blockers delay or prevent aneurysm formation. 3-6 In this clinical study, we have investigated the hypothesis that -adrenergic blockade reduces the rate of AAA expansion. MATERIALS AND METHODS From 1977 to 1991, all patients with AAA less than 5 cm in size or with medical contraindications to surgery were prospectively monitored with serial ultrasound examinations. Aneurysms less than 3.0 cm in diameter as measured in the sagittal anteroposterior plane by ultrasonography were excluded in this study. Serial ultrasonography measurements were performed every 3 to 12 months. Inclusion in the study required a total follow-up of at least 6 months and two or more ultrasound examinations. Data collection also included the patient's age at study entry, complete medical history, and blood pressure recordings at the time of each ultrasound 727
2 728 Gadowski, Pilcher, and Ricci JOURNAL OF VASCULAR SURGERY April 1994 (cm/yr) 1 I_GROUP I DGROUP III UJ 0.8 p=0.02 * a: o a: o em em ANEURYSM DIAMETER p<0.05 ** em Fig. 1. AAA expansion rates of group I (no (3-bloeker) and group II «(3-bloeker) classified by aneurysm size. Asterisk represents large (;;e: 5 em) versus small «5 em) AM, group 1. Double asterisk represents group I versus group II, large AAA. measurement. Follow-up was obtained until the point of AAA rupture, patient death, elective AAA repair, or the most recent ultrasound examination results. The decision to undergo surgery was made on an individual basis and was usually based on AAA growth to greater than S cm in diameter. Patients were divided into two groups: those who did not receive any f3-blockers during the entire period of study (group I), and those who received f3-blockers (group II). Only patients receiving continuous f3-blocker therapy during the entire period of study were included in group II. Most patients receiving f3-blockers were receiving these drugs for long-term therapy of hypertension or coronary artery disease. Nine patients were given f3-blockers specifically to retard AAA expansion. Patients were classified according to AAA size as follows: 3.0 to 3.9 cm, 4.0 to 4.9 cm, S.O cm or greater. Linear AAA expansion rates were calculated within each size classification. Statistical analysis was performed with one-way analysis of variance for group comparisons, Student's t test for continuous variables, chi-squared analysis for categorical variables, and linear regression analysis. A p value of less than O.OS was considered significant. Data are expressed as the mean ± standard deviation. RESULTS During a IS-year period, 121 patients met the study criteria listed above. The study population consisted of 71 % men with a mean age of 68 ± 9 years. Mean follow-up was 43 ± 29 months and the mean number of ultrasound examinations per patient was S.6 ± 3.4. Thirteen patients had aneurysm rupture (11%). Overall AAA expansion rate for the entire population was 0.38 ± 0.44 cm/yr. No correlation was found between AAA expansion rate and patient age, sex, systolic blood pressure, diastolic blood pressure, pulse pressure, or mean arterial pressure. In the nine patients given f3-blockers specifically for their MA, blood pressure before and after the initiation of therapy was not significantly altered. Characteristics for group I and group II are shown in Table I. Overall the rate of expansion of aneurysms in group I was 0.44 ± 0.42 cm/yr, compared with group II, which was 0.30 ± 0.31 cm/yr (p = 0.07). In group I, 31 (60%) patients had expansion rates that exceeded the population mean of 0.38 cm/yr, compared with six (19%) patients in group II (p = 0.03). Expansion rate categorized by AAA size are depicted in Fig. 1. There were no significant differences in sex, age, number of examinations, follow-up, or blood pressure between patients in separate size categories. Large aneurysms (S cm) expanded significantly faster than smaller aneurysms in group I, however, this was not true for patients in group II. Among AAA of S cm or greater, a significant difference in growth rate between group I and group II was also observed (Fig. 1). AAA rupture occurred in 11 patients in group I (13%) and two patients in group II (S%); however, this difference was not statistically significant (p = 0.33). A total of 34 patients with AAA S cm or larger were treated without operation because of medical contraindications to surgery or refusal to undergo surgery. Ten of these patients had AAA that ruptured, including two patients receiving f3-blockers. Mean AAA diameter at the time of rupture was 6.9 ± 0.9 cm in the untreated patients, and was 7.2 and 6.S cm in the two patients on f3-blockers. The mean expansion rate of aneurysms that subsequently ruptured was significantly greater than that of nonruptured AAA in this subset of 34 patients: 0.82 ± 0.74 cm/yr vs ± 0.41 cm/yr, p = Within group II, most patients received nonselective 131/132 blockade with propranolol. The remaining patients received the 131 selective drugs metoprolol and atenolol. Patients treated with propranolol had a significantly lower mean growth rate than those treated with selective f3-blockers (Table II).
3 JOURNAL OF VASCULAR SURGERY Volume 19, Number 4 Gaduwski, Pilcher, and Ricci 729 Table I. Characteristics of group I (no l3-blocker) versus group II (l3-blocker) Group I n = 83 Group II n = 38 p Value Age (years) Sex (% male) Initial size (cm) No. examinations/patient Follow-up (mo) BP systolic (mm Hg) BP diastolic (mm Hg) MAP (mmhg) Rupmre (No.) Expansion rate (cm/yr) 68 ± 8 71% 4.0 ± ± ± ± ± ± (13%) 0.44 ± ± 10 74% 4.0 ± ± ± ± ± ± 10 2 (5%) 0.30 ± BP, Blood pressure; iwap, mean arterial pressure. Table II. Comparison of propranolol versus 131 selective drugs within group II Drug No. Dose (mg/day) Initial AAA size (em) Expansion rate (em/yr) Propranolol Atenolol Metoprolol ± ± ± ± 0.8* 4.6 ± u.8* 0.20 ± 0.23t 0.42 ± 0.37t *p = tp = DISCUSSION There is currently no pharmacologic therapy that has been clearly shown to be clinically effective in preventing abdominal aortic aneurysm enlargement and rupture. In contrast to atherosclerotic aneurysms of the aorta, established treatment of aortic dissection includes l3-blockade, which lowers blood pressure as well as the rate of rise of the aortic pressure wave (dp/dt), effectively reducing the extent of the dissection, risk of rupture, and dilation of the aortic root. 7,8 According to the Law of LaPlace, arterial hypertension increases aortic wall tension and has clinically been related to an increased rate of AAA rupture. 9 Recent experimental studies have confirmed the long held clinical suspicion that hypertension also accelerates AAA expansion. 10,11 By controlling blood pressure, it seems logical that l3-blockers might inhibit AAA expansion. Limited clinical data exists regarding the influence of l3-adrenergic blockade upon the expansion rate of AAA. In a small retrospective study, Leach and coworkers2 monitored 27 patients with AAA, 12 of whom were undergoing l3-blocker therapy, over a mean period of 34 months. The expansion rate for the latter group was 0.17 cm/yr; for those not receiving l3-blockers the rate was 0.44 cm/yr. This comparison did not reach statistical significance (p = 0.09). However, rapid aneurysm expansion, which the authors define as a rate more than the mean expansion rate for the entire study (> 0.32 cm/yr), occurred in only 1 of 12 patients receiving l3-blockade (8%) compared with eight of 15 patients (53%) not receiving l3-blockers (p = 0.013). Leach et al. 2 also showed a weak correlation between blood pressure and AAA expansion rate. However, in this study we were unable to demonstrate any significant correlation between systolic, diastolic, mean, or pulse pressures and AAA expansion rate. Furthermore, we could not demonstrate a difference in systolic, diastolic, or mean arterial pressures in patients receiving l3-blockers compared with untreated patients. Unfortunately, other hemodynamic variables affected by l3-blockers such as dp/dt are difficult to routinely assess in a clinical setting and were not investigated in this study. Nevertheless, if l3-blockers do indeed stabilize AAA, the mechanism is not clearly related to their hemodynamic effects. Experimental evidence suggests that the effect of propranolol on limiting aneurysm formation may be independent of changes in blood pressure and dp /dt, and may involve changes in aortic wall connective tissue metabolism. Brophy and coworkers 3 demonstrated that propranolol could delay the formation of aneurysms in the blotchy mouse, a strain that develops spontaneous aortic aneurysms. They subsequently showed increases of 147% in skin elastin and 54% in skin collagen when the mice were treated with
4 730 Gadowski, Pilcher, and Ricci JOURNAL OF VASCULAR SURGERY April 1994 propranolol. 12 Although this suggested to the authors a direct effect of propranolol treatment on tissue matrix metabolism, no direct study of aortic tissue was undertaken nor were hemodynamic parameters measured. Simpson and Boucek 13 have investigated drug effects in turkeys fed B-aminopropionitrile fumarate (BAPN), an inhibitor of lysyl oxidase, the enzyme that catalyzes an essential step in the formation of elastin and collagen cross-links. Broad-breasted white turkeys that spontaneously develop hypertension, tachycardia, and atherosclerosis by 5 weeks of age also develop dissecting aneurysms when fed BAPN. BAPN has no hemodynamic effects, decreases aortic ring tensile strength and results in a death from aneurysm rupture of 44%. Nonspecific /3-blockade with propranolol decreased heart rate, blood pressure, and dp /dt while increasing aortic tensile strength and limiting aortic rupture to 1%. The /31 selective drugs practolol and sotalol had similar hemodynamic effects but resulted in 13 % and 5 % rupture rates, respectively. On the basis of these differences, the authors suggest a direct action of propranolol on aortic elastin and collagen. Other studies from this group have suggested a direct dose-response relationship between propranolol and aortic tensile strength and increased elastin crosslinking, but not between the /31 selective drugs and these characteristics. S Similarly, in our study, propranolol was associated with a decreased AAA expansion rate when compared with the /31 selective drugs metoprolol and atenolol. It remains to be shown whether this phenomenon is attributable to the /32 effects of propranolol on vascular smooth muscle or some other unique property of the drug. Inhibiting /32 receptors in bronchiolar smooth muscle may exacerbate obstructive pulmonary disease, which is a potential disadvantage in the use of propranolol versus the /31 cardioselective antagonists. Our data confirm the work by Leach et al. 2 with a larger patient population and lend support to the hypothesis that /3-blockade retards AAA expansion. Although the overall mean expansion rate differences between the treatment groups did not achieve statistical significance at the 5% level, significantly fewer patients in group II (/3-blocker) had expansion rates above the population mean of 0.38 cm/yr. Additionally, among large AAA, expansion rate in patients treated with /3-blocker was significantly less than in untreated patients. Interestingly, our data also suggest that in patients not receiving /3-blockers, AAA expand more rapidly as they enlarge. This phenomenon has been previously observed in work by Nevitt et al.,14 and in a recent study by Limet et al. 1S In the latter study, the authors suggest that AAA expansion is actually better described by an exponential growth curve rather than a linear curve. Rapid AAA expansion (> 0.5 cm/yr) has been believed to represent AAA instability and a high risk for rupture. 16 Those large AAA (> 5 cm) that went on to rupture had a significantly greater expansion rate than those that did not rupture. Therefore it intuitively follows that a reduction in the expansion rate by /3-blocker therapy might ultimately decrease the rate of rupture of large AAA. Although the incidence of rupture was lower in the /3-blocker group, this difference did not achieve statistical significance, possibly caused by a relatively small sample size. In summary our study of 121 patients with AAA shows a significantly reduced expansion rate in patients with large AAA (2: 5 cm) receiving /3-adren ergic antagonists. The clinical utility of /3-blockade in AAA could be important in the nonoperative treatment in patients with serious medical risks or contraindications for surgery. Although /3-blockade has clear benefit in patients with acute aortic dissection, the possible benefit of preventing AAA rupture remains to be shown. To clearly define the effect of /3-blockade in AAA expansion and to provide better criteria for clinical indications further study is needed. The results presented here combined with those previously published emphasize the need for a randomized clinical trial. REFERENCES 1. Ernst CB. Current concepts: abdominal aortic aneurysm. N Eng J Med 1993;328: Leach SD, Toole AL, Stern H, DeNatale RW, Tilson MD. Effect of j3-adrenergic blockade on the growth rate abdominal aortic aneurysms. Arch Surg 1988;123: Brophy CM, Tilson JE, Tilson MD. Propranolol delays the formation of aneurysms in the male Blotchy mouse. J Surg Res 1988;44: Simpson CF, Boucek RJ, Noble NL. Influence of do, 1-, and dl-propranolol and practolol on j3-aminopropionirtiie induced aortic rupture of turkeys. Toxicol Appl Pharmacal 1976;38: Boucek RJ, Gunja-Smith Z, Noble NL, Simpson CF. Modulation by propranolol of the Iysyl cross-links in aortic elastin and collagen of the aneurysm-prone turkey. Biochem Pharmacol 1983;32: Siaiby J, Ricci MA, Gadowski GR, Hendley ED, Pilcher DB. Propranolol reduces the size of aortic aneurysms in hypertensive rats. Surg For 1993;44: Wheat MW, Jr. Acute dissecting aneurysms of the aorta: diagnosis and treatment. Am Heart J 1988;99: Pyeritz RE. Propranolol retards aortic root dilation in the Marfan syndrome. Circulation 1983;68(suppl 3):365.
5 JOURNAL OF VASCULAR SURGERY Volume 19, Number 4 Gadowski, Pilcher, and Ricci SpittelJA, Jr. Hypertension and arterial aneurysms. J Am Coli CardioI1983;1: Gadowski GR, Ricci MA, Hendley ED, Pilcher DB. Hypertension accelerates the growth of experimental aortic aneurysms. J Surg Res 1993;54: Andijar S, Osborne-Pellegrin M, Coutard M, Jean-Baptiste M. Arterial hypertension and aneurysmal dilation. Kidney Int 1992;41 (suppl 37):S Brophy CM, Tilson JE, Tilson MD. Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm prone Blotchy mouse. J Surg Res 1989;46: Simpson CF, Boucek RJ. The J3-aminopropionitrile fed turkey: a model for detecting potential drug action on arterial tissue. Cardiovasc Res 1983;17: Nevitt MP, Ballard DJ, Hallett JW, Jr. Prognosis of abdominal aortic aneurysms: a population based study. N Eng J Med 1989;321: Limet R, Sakalihassan N, Adelin A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J VAse SURG 1991;14: Bernstein EF, Dilley RB, Goldberger LE, Gosink BB, Leopold GR. Growth rates of small abdominal aortic aneurysms. Surgery 1976;80: Submitted June 15, 1993; accepted Aug 26, BOUND VOLUMES AVAILABLE TO SUBSCRIBERS Bound volumes of the JOURNAL OF VASCULAR SURGERY for 1994 are available to subscribers only. They may be purchased from the publisher at a cost of $76.00 for domestic, $97.32 for Canadian, and $92.00 for international subscribers for Vol. 19 (January to June) and Vol. 20 (July to December). Price includes shipping charges. Each bound volume contains a subject and author index, and all advertising is removed. Copies are shipped within 60 days after publication of the last issue in the volume. The binding is durable buckram with the journal name, volume number, and year stamped in gold on the spine. Payment must accompany all orders. Contact Subscription Services, Mosby-Year Book, Inc., Westline Industrial Dr., St. Louis, MO , USA. In the United States call toll free (800) , ext In Missouri or foreign countries call (314) Subscriptions must be in force to qualify. Bound volumes are not available in place of a regular JOURNAL subscription.
Medical management of abdominal aortic aneurysms
Medical management of abdominal aortic aneurysms Definition of AAA - Generally a 50% increase in native vessel diameter - Diameter 3 cm - Relative measures compared with nondiseased aortic segments less
More informationScreening for Abdominal Aortic Aneurysm During Transthoracic Echocardiography in a Hypertensive Patient Population
Screening for Abdominal Aortic Aneurysm During Transthoracic Echocardiography in a Hypertensive Patient Population Peter C. Spittell, MD, Io-Ellen Ehrsam, RDCS, RVT, RDMS, Laurie Anderson, RDCS, and James
More informationMEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Hideki Akamatsu, MD a Yuzo
More informationWhat Are the Current Guidelines for Treating Thoracic Aortic Disease?
What Are the Current Guidelines for Treating Thoracic Aortic Disease? Eric M. Isselbacher, M.D. Director, MGH Healthcare Transformation Lab Co-Director, MGH Thoracic Aortic Center Associate Professor of
More informationDisclosures: Acute Aortic Syndrome. A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO
Acute Aortic Syndrome Disclosures: A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO No financial relationships to disclose 1 Acute Aortic
More informationDR.RUPNATHJI( DR.RUPAK NATH )
6. Screening for Abdominal Aortic Aneurysm Burden of Suffering RECOMMENDATION There is insufficient evidence to recommend for or against routine screening of asymptomatic adults for abdominal aortic aneurysm
More informationPropranolol for small abdominal aortic aneurysms: Results of a randomized trial
CLINICAL RESEARCH STUDIES Propranolol for small abdominal aortic aneurysms: Results of a randomized trial The Propranolol Aneurysm Trial Investigators, Toronto, Ontario, Canada Purpose: Animal and human
More informationAbdominal Aortic Aneurysm
Abdominal Aortic Aneurysm David N. Duddleston, MD VP and Medical Director Southern Farm Bureau Life Jackson, Mississippi A Case Ms. Ima Bolgin,, age 54, $1.2 million, sent to you for review. Smoker, ½
More informationVariables that affect the expansion outcome of small abdominal aortic
Variables that affect the expansion outcome of small abdominal aortic Jack L. Cronenwett, MD, Steven K. Sargent, MD, Michael H. Wall, MD, Mary L. Hawkes, RN, Daniel H. Freeman, Phi3, Bradley J. Dain, MS,
More informationA very short lecture.
Medical Treatment of Type A Aortic Dissection: Tales of Turkeys, Tygon Tubing, and Evolving Paradigms The Houston Aortic Symposium April 4-6, 2008 John A. Elefteriades, MD William W.L. Glenn Professor
More informationSCREENING AND MANAGEMENT
SCREENING AND MANAGEMENT OF ABDOMINAL AORTIC ANEURYSM (AAA) IN HIGH RISK POPULATIONS Brindy Chris Paet, BSN RN. Augustina Manuzak, MD, MPH, PhD CONTENTS Introduction Natural History of the Disease Disease
More informationResection of abdominal aortic aneurysm patients with low ejection fractions
Resection of abdominal aortic aneurysm patients with low ejection fractions in Richard L. McCann, MD, and Walter G. Wolfe, MD, Durham, N.C. The perioperative and long-term survival of patients who undergo
More informationaortic aneurysm in the patient cardiac transplantation
Abdominal undergoing aortic aneurysm in the patient cardiac transplantation Joseph J. Piotrowski, MD, Kenneth E. McIntyre, MD, Glenn C. Hunter, MD, Gulshan K. Sethi, MD, Victor M. Bernhard, MD, and Jack
More informationAbdominal Aortic Aneurysm Clinical Guideline
Abdominal Aortic Aneurysm Clinical Guideline Definition: An abdominal aortic aneurysm (AAA) is an enlargement of the lower part of the aorta that extends through the abdominal area (at times, the upper
More informationThe risk of rupture in untreated aneurysms: The impact of size, gender, and expansion rate
The risk of rupture in untreated aneurysms: The impact of size, gender, and expansion rate Peter M. Brown, MD, David T. Zelt, MD, and Boris Sobolev, PhD, Kingston, Ontario, Canada Objective: The purpose
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More informationThe effects of improved hemodynamics on aortic dimensions in patients undergoing heart transplantation
The effects of improved hemodynamics on aortic dimeio in patients undergoing heart traplantation David A. Bull, MD, Leigh A. Neumayer, MD, Bryan J. Venerus, MD, Charles W. Putnam, MD, Luis Rosado, MD,
More informationSurgical indications in ascending aorta aneurysms: What do we know? Jean-Luc MONIN, MD, PhD. Institut Mutualiste Montsouris, Paris, FRANCE
Surgical indications in ascending aorta aneurysms: What do we know? Jean-Luc MONIN, MD, PhD. Institut Mutualiste Montsouris, Paris, FRANCE Disclosures related to this talk : NONE 2 Clinical case A 40 year-old
More informationRupture in small abdominal aortic aneurysms
ORIGINAL CLINICAL STUDIES Rupture in small abdominal aortic aneurysms Stephen C. Nicholls, MD, Jon B. Gardner, MD, Mark H. Meissner, MD, and Kaj H. Johansen, MD, PhD, Seattle, Wash Background: The decision
More informationSupplementary Figure 1:
Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas
More informationThe prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients
The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients Michael J. Englesbe, MD, a Audrey H. Wu, MD, MPH, b Alexander W. Clowes, MD, a and R. Eugene Zierler,
More informationAORTIC DISSECTIONS Current Management. TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida
AORTIC DISSECTIONS Current Management TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida DISCLOSURES Terumo Medtronic Cook Edwards Cryolife AORTIC
More informationBeta blockers in primary hypertension. Dr. Md. Billal Alam Associate Professor of Medicine DMC
Beta blockers in primary hypertension Dr. Md. Billal Alam Associate Professor of Medicine DMC Development of antihypertensive drugs Beta blockers 1958 - The first beta-blocker, dichloroisoproterenol, was
More informationAortic Aneurysms: What s s New?
25th Annual Advances in Heart Disease 12 December 2008 Aortic Aneurysms: What s s New? Melvin D. Cheitlin, M.D., MACC Emeritus Professor of Medicine UCSF 1 AAA in the U.S. 13th cause of death -16,000 deaths/yr
More informationNatural History of a Dilated Ascending Aorta After Aortic Valve Replacement
Circ J 2005; 69: 392 396 Natural History of a Dilated Ascending Aorta After Aortic Valve Replacement Katsuhiko Matsuyama, MD; Akihiko Usui, MD; Toshiaki Akita, MD; Masaharu Yoshikawa, MD; Masaomi Murayama,
More informationMechanical Properties of Aneurysms of the Descending Human Aorta
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 3-4-2008 Mechanical Properties of Aneurysms of the Descending Human
More informationAnother pregnancy after a previous aortic dissection in pregnancy?
Another pregnancy after a previous aortic dissection in pregnancy? Dr Leisa Freeman GUCH & Maternal Cardiology Unit Norfolk & Norwich University Hospital UK Arterial wall changes & haemodynamic effects
More informationSeroepidemiological associations between high density lipoprotein and abdominal aortic aneurysms
Seroepidemiological associations between high density lipoprotein and abdominal aortic aneurysms Jes S. Lindholt(1,2), Elena Burillo (3), Jesper Laustsen(4), Jose Luis Ventura-Martin(3) Department of Thoracic,
More informationAsymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses
Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses R. James Valentine, MD, John D. Martin, MD, Smart I. Myers, MD, Matthew
More informationAn Overview of Post-EVAR Endoleaks: Imaging Findings and Management. Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC
An Overview of Post-EVAR Endoleaks: Imaging Findings and Management Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC Disclosure Slide Mark O. Baerlocher: Current: Consultant for Boston
More informationCURRENT UNDERSTANDING: ANATOMY & PHYSIOLOGY TYPE B AORTIC DISSECTION ANATOMY ANATOMY. Medial degeneration characterized by
DISCLOSURES CURRENT UNDERSTANDING: INDIVIDUAL None & PHYSIOLOGY TYPE B AORTIC DISSECTION INSTITUTIONAL Cook, Inc Not discussing off-label use of anything Medial degeneration characterized by Smooth muscle
More informationPregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016
1 Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Cardiovascular Effects of Pregnancy Anatomic Ventricular muscle mass increases
More informationArterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski
Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly Piotr Jankowski I Department of Cardiology and Hypertension CM UJ, Kraków, Poland piotrjankowski@interia.pl Vienna,
More informationAORTIC ANEURYSM. howmed.net
AORTIC ANEURYSM howmed.net ANATOMY It is important to understand the anatomy of the aorta Need to know the extent of the aneurysm Need to know the vessels involved This helps with Medical or Surgical management
More informationWhat Determines Aortic False Lumen Growth Post Dissection?
Aortic Dissections What Determines Aortic False Lumen Growth Post Dissection? UCSF Vascular Symposium April 26, 2012 Most common aortic emergency Incidence of aortic dissections are 2/100,000 person-years
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationCT angiography in type I acute aortic dissection complicated with malperfusion - a visual review of obstruciton patterns
CT angiography in type I acute aortic dissection complicated with malperfusion - a visual review of obstruciton patterns Eneva M. St. Ekaterna University Hospital Report objectives 1. Review malperfusion
More informationAbdominal Aortic Aneurysms. A Surgeons Perspective Dr. Derek D. Muehrcke
Abdominal Aortic Aneurysms A Surgeons Perspective Dr. Derek D. Muehrcke Aneurysm Definition The abnormal enlargement or bulging of an artery caused by an injury or weakness in the blood vessel wall A localized
More informationSports Participation in Patients with Inherited Diseases of the Aorta
Sports Participation in Patients with Inherited Diseases of the Aorta Yonatan Buber, MD Adult Congenital Heart Service Leviev Heart Center Safra Childrens Hospital Disclosures None Patient Presentation
More informationAbdominal Aortic Aneurysms (AAA): Management in 2012
Abdominal Aortic Aneurysms (AAA): Management in 2012 Matthew S. Edwards, MD, MS, FACS Associate Professor of Surgery and Public Health Sciences Department of Vascular and Endovascular Surgery General Considerations
More informationTHORACIC AORTIC DISSECTION
The Essence of Aortic Dissection THORACIC AORTIC DISSECTION Aortic dissection can be classified as acute if it s onset has been less than 14 days or chronic if its onset has been more than 14 days. Mortality
More informationOriginal Research Time-Course of Mechanical Changes of the Rat Aorta Following Chronic Beta-Blocker Treatment
Hellenic J Cardiol 21; 51: 19-26 Original Research Time-Course of Mechanical Changes of the Rat Aorta Following Chronic Beta-Blocker Treatment Dimitrios P. So k o l i s*, Ko n s t a n t i n o s M. La m
More informationExperience of endovascular procedures on abdominal and thoracic aorta in CA region
Experience of endovascular procedures on abdominal and thoracic aorta in CA region May 14-15, 2015, Dubai Dr. Viktor Zemlyanskiy National Research Center of Emergency Care Astana, Kazakhstan Region Characteristics
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Measure #258: Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) National Quality
More informationAbdominal aortic aneurysm rupture rates: A 7-year follow-up of the entire abdominal aortic aneurysm population detected by screening
ORIGINAL ARTICLES Abdominal aortic aneurysm rupture rates: A 7-year follow-up of the entire abdominal aortic aneurysm population detected by screening R. Alan P. Scott, MS, FRCS, Paul V. Tisi, FRCS Ed,
More informationClinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE)
Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon The Netherlands
More informationBlood Vessel Mechanics
Blood Vessel Mechanics Ying Zheng, Ph.D. Department of Bioengineering BIOEN 326 11/01/2013 Blood Vessel Structure A Typical Artery and a Typical Vein Pressure and Blood Flow Wall stress ~ pressure Poiseuille
More informationAORTIC DISSECTION. DISSECTING ANEURYSMS OF THE AORTA or CLASSIFICATION
DISSECTING ANEURYSMS OF THE AORTA or AORTIC DISSECTION CLASSIFICATION DeBakey classified aortic dissections into types I, II, and III :- Type I dissection the tear site originates in the ascending aorta,
More informationUvA-DARE (Digital Academic Repository) Marfan syndrome: Getting to the root of the problem Franken, Romy. Link to publication
UvA-DARE (Digital Academic Repository) Marfan syndrome: Getting to the root of the problem Franken, Romy Link to publication Citation for published version (APA): Franken, R. (2016). Marfan syndrome: Getting
More informationMetoprolol Succinate SelokenZOC
Metoprolol Succinate SelokenZOC Blood Pressure Control and Far Beyond Mohamed Abdel Ghany World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 1 Death Rates From Ischemic
More informationIs close radiographic and clinical control after repair of acute type A aortic dissection really necessary for improved long-term survival?
doi:10.1510/icvts.2010.239764 Interactive CardioVascular and Thoracic Surgery 11 (2010) 620 625 www.icvts.org Best evidence topic - Aortic and aneurysmal Is close radiographic and clinical control after
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationExercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine
Exercise Test: Practice and Interpretation Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine 2 Aerobic capacity and survival Circulation 117:614, 2008
More informationSldn perfusion pressure in the prediction of healing in diabetic patients with ulcers or gangrene of the foot
Sldn perfusion pressure in the prediction of healing in diabetic patients with ulcers or gangrene of the foot I. Faris, M.D., F.R.A.C.S., and H. Duncan, B.M., B.S., Adelaide, Australia The measurement
More informationThe Management and Treatment of Ruptured Abdominal Aortic Aneurysm (RAAA)
The Management and Treatment of Ruptured Abdominal Aortic Aneurysm (RAAA) Disclosure Speaker name: Ren Wei, Li Zhui, Li Fenghe, Zhao Yu Department of Vascular Surgery, The First Affiliated Hospital of
More informationAbdominal Aortic Aneurysm - Part 1. Learning Objectives. Disclosure. University of Toronto Division of Vascular Surgery
University of Toronto Division of Vascular Surgery Abdominal Aortic Aneurysm - Part 1 Dr Mark Wheatcroft & Dr Elisa Greco Vascular Surgeon, St Michael s Hospital, Toronto & University of Toronto Disclosure
More information2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #258: Rate of Open Repair of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) National Quality Strategy
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationDepartments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece
Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece ARGYRIS Vassilis, PEROULIS Michalis, MATSAGKAS Miltiadis, BECHLIOULIS Aris, MICHALIS Lampros, NAKA
More informationCardiovascular System
Cardiovascular System BELLWORK: Define using technology angio hemo/hema cardio brady as in bradycardia tachy as in tachycardia Standards 8) Outline basic concepts of normal structure and function of all
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next
More informationAortic Dissection in BAV Patients: The IRAD Experience and Beyond
Aortic Dissection in BAV Patients: The IRAD Experience and Beyond Eduardo Bossone, MD, Ph.D, FESC, FACC Cardiology Division - Heart Dept. University of Salerno, Italy I have no financial relationships
More informationTargeting nanoparticles to degenerated elastin: A new pathway to deliver drugs for pulmonary and cardiovascular diseases
Targeting nanoparticles to degenerated elastin: A new pathway to deliver drugs for pulmonary and cardiovascular diseases Naren Vyavahare, Saketh Karamched, Aniqa Chowdhury, Vaideesh Parasaram. Nasim Nosoudi,
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next
More informationFunctional anatomy of the aortic root. ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη
Functional anatomy of the aortic root ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη What is the aortic root? represents the outflow tract from the LV provides
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next
More informationAbdominal and Thoracic Aortic Aneurysm Modeling
American Journal of Applied Sciences 5 (8): 1052-1058, 2008 ISSN 1546-9239 2008 Science Publications Abdominal and Thoracic Aortic Aneurysm Modeling Mona Abdolrazaghi, Mehdi NavidBakhsh and Kamran Hassani
More informationAcute Aortic Syndromes
Acute Aortic Syndromes Carole J. Dennie, MD Acute Thoracic Aortic Syndromes Background Non-Traumatic Acute Thoracic Aortic Syndromes Carole Dennie MD FRCPC Associate Professor of Radiology and Cardiology
More informationImportance of changes in thoracic and abdominal aortic stiffness following stent graft implantation
14/9/2018 Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation Christos D. Liapis, MD, FACS, FRCS, FEBVS Professor (Em) of Vascular Surgery National & Kapodistrian
More informationCVS Hemodynamics. Faisal I. Mohammed, MD,PhD.
CVS Hemodynamics Faisal I. Mohammed, MD,PhD. Objectives point out the physical characteristics of the circulation: distribution of blood volume total cross sectional area velocity blood pressure List the
More informationRefinements in Mathematical Models to Predict Aneurysm Growth and Rupture
Refinements in Mathematical Models to Predict Aneurysm Growth and Rupture RAMON BERGUER, a,b JOSEPH L. BULL, a,b AND KHALIL KHANAFER a a Vascular Mechanics Laboratory, Department of Biomedical Engineering,
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Quality ID #259: Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative
More informationAscending Thoracic Aorta: Postsurgical CT Evaluation
Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martinez Jimenez, MD GOALS Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martínez MD smartinez-jimenez@saint-lukes.org Saint
More informationLate False Lumen Expansion Predicted by Preoperative Blood Flow Simulation in a Patient with Chronic Type B Aortic Dissection
Accepted Manuscript Late False Lumen Expansion Predicted by Preoperative Blood Flow Simulation in a Patient with Chronic Type B Aortic Dissection Chikara Ueki, MD, Hiroshi Tsuneyoshi, MD, PhD PII: S0022-5223(18)32652-7
More informationSURGICAL INTERVENTION IN AORTOPATHIES ZOHAIR ALHALEES, MD RIYADH, SAUDI ARABIA
SURGICAL INTERVENTION IN AORTOPATHIES ZOHAIR ALHALEES, MD RIYADH, SAUDI ARABIA In patients born with CHD, dilatation of the aorta is a frequent feature at presentation and during follow up after surgical
More informationPREGNANCY AND CONGENITAL HEART DISEASE
PREGNANCY AND CONGENITAL HEART DISEASE SIDDHARTH JADHAV M.D. Assistant Professor of Radiology E.B. Singleton Department of Pediatric Radiology Texas Children's Hospital COMMERCIAL DISCLOSURE - None Objectives
More information5cm. 5cm AAA. 5cm. 5cm. 8 4cm. 5cm 0.6. abdominal aortic aneurysm; AAA. Tel:
15 3 9 2006 5cm 5cm AAA 5cm5cm 8 4cm AAA 5cm 4cm5cm 5cm AAA 261 1 260 99.6 125 135 52 5cm 14 5cm5cm 4cm 5 77.8 58.34cm 0.6 76.8 75.1 4cm 5cm 4cm 74.8 5cm 78.6 5cm 5cm 15 3 9 2006 abdominal aortic aneurysm;
More informationEpidemiology of Aortic Aneurysm Repair in the United States from 1993 to 2003
Epidemiology of Aortic Aneurysm Repair in the United States from 1993 to 2003 JOHN A. COWAN, JR., JUSTIN B. DIMICK, PETER K. HENKE, JOHN RECTENWALD, JAMES C. STANLEY, AND GILBERT R. UPCHURCH, Jr. University
More informationSpotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound
Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound Department of Cardiovascular Medicine Heart and Vascular Institute
More informationDENOMINATOR: Patients aged 18 and older with infrarenal non-ruptured endovascular AAA repairs
Measure #347 (NQF 1534): Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) Who Die While in Hospital National Quality Strategy Domain: Patient
More informationCurrent treatment of Aortic Aneurysms and Dissections. Adam Keefer, MD, FACS Sean Hislop, MD, FACS
Current treatment of Aortic Aneurysms and Dissections Adam Keefer, MD, FACS Sean Hislop, MD, FACS Patient 1 69 year old well-educated man with reoccurring pain in his upper abdomen and a pulsatile mass.
More informationSports and Aortic Disease
The 9th Annual meeting of the BWGACHD Sports and Exercise in Congenital Heart Disease Sports and Aortic Disease Julie De Backer Ghent University Hospital Why? Avoid SCD Flo Hyman (1954-1986) Captain of
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Measure #347 (NQF 1534): Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non- Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) Who Die While in Hospital National Quality Strategy Domain:
More informationHEART CONDITIONS IN SPORT
HEART CONDITIONS IN SPORT Dr. Anita Green CHD Risk Factors Smoking Hyperlipidaemia Hypertension Obesity Physical Inactivity Diabetes Risks are cumulative (multiplicative) Lifestyles predispose to RF One
More informationBIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1
BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 Terms you should understand: hemorrhage, intrinsic and extrinsic mechanisms, anoxia, myocardial contractility, residual
More informationENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
More informationAnimesh Rathore, MD 4/22/17. The Great Debate 45yo Man With Uncomplicated Acute TBAD: The Case For Medical Management
Animesh Rathore, MD 4/22/17 The Great Debate 45yo Man With Uncomplicated Acute TBAD: The Case For Medical Management Disclosures Just a young vascular surgeon who would like to keep his job My opponent
More informationClinical application of Arterial stiffness. pulse wave analysis pulse wave velocity
Clinical application of Arterial stiffness pulse wave analysis pulse wave velocity Arterial system 1. Large arteries: elastic arteries Aorta, carotid, iliac, Buffering reserve: store blood during systole
More informationSBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006
Management of Hypertension in Patients with CAD M. Mohsen Ibrahim, MD Cardiology Department- Cairo University 1. What is the optimal BP in patients with hypertension and CAD? 2. What is the minimum safe
More informationEarly outcomes of acute retrograde dissection in the aortic arch and the ascending aorta data from IRAD
Early outcomes of acute retrograde dissection in the aortic arch and the ascending aorta data from IRAD Foeke JH Nauta, MD, PhD Resident Cardiothoracic Surgery, Academic Medical Center, Amsterdam Disclosure
More informationHow well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study
(2000) 14, 429 433 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh ORIGINAL ARTICLE How well do office and exercise blood pressures predict sustained hypertension?
More information한국학술정보. Clinical Characteristics of the Abdominal Aortic Aneurysm
Clinical Characteristics of the Abdominal Aortic Aneurysm Pil Cho Choi, M.D., Sang Kuk Han, M.D., Dong Hyuk Shin, M.D., Woon Yong Kwon, M.D., Hyoung Gon Song, M.D., Keun Jeong Song, M.D., Yeon Kwon Jeong,
More informationRespiratory Function Testing Is Safe in Patients With Abdominal Aortic Aneurysms.
Respiratory Function Testing Is Safe in Patients With Abdominal Aortic Aneurysms. Author Zagami, Debbie, Wilson, Jessica, Bodger, Alanna, Sriram, Krishna Published 2014 Journal Title Vascular and Endovascular
More informationSESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION D5 Session Description: The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM
More informationWhich method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호
Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호 Arterial stiffness Arterial stiffness is inversely related to arterial
More informationEffects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris
Br. J. clin. Pharmac. (1987), 23, 391-396 Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris J. V. SHERIDAN, P. THOMAS, P. A. ROUTLEDGE & D. J. SHERIDAN Departments
More informationFollow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011
Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011 Susan E. Wiegers, MD, FASE Director of Clinical Echocardiography Hospital of the University of Pennsylvania Disclosure
More informationAortic stenosis (AS) is common with the aging population.
New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting
More informationEarly View Article: Online published version of an accepted article before publication in the final form.
: Online published version of an accepted article before publication in the final form. Journal Name: Journal of Case Reports and Images in Medicine doi: To be assigned Early view version published: October
More information